Clinical Trials on Heart Diseases in Japan

Total 6960 results

Kumamoto University

Completed

Plaque REgression With Cholesterol Absorption Inhibitor or Synthesis Inhibitor Evaluated by IntraVascular UltraSound (PRECISE-IVUS)

Coronary Artery Disease | Hypercholesterolemia

Japan
Pfizer

Completed

Safety and Effectiveness of Apixaban Compared to Warfarin in Secondary Prevention in Patients With Atrial Fibrillation

Non-valvular Atrial Fibrillation

Japan
Mitsui Memorial Hospital
Mitsukoshi Health and Welfare Foundation

Completed

DPP-4 Inhibitor and Serum BNP Level of Diabetic Patients With Congestive Heart Failure

Heart Failure | Diabetes Mellitus

Japan
Bayer

Completed

A Study to Learn About Venous Thromboembolism (VTE) Treatment With Rivaroxaban in Japanese Patients Using a Claims Database

Treatment of Venous Thromboembolism

Japan
Bristol-Myers Squibb

Completed

A Study of Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan

Non-Valvular Atrial Fibrillation (NVAF)

Japan
Boehringer Ingelheim

Completed

Medical Need of OAC Reversal

Atrial Fibrillation

Japan
Ministry of Health, Labour and Welfare, Japan

Completed

Carvedilol Versus Metoprolol for the Prevention of Atrial Fibrillation After Off-Pump Coronary Bypass Surgery

Coronary Disease | Atrial Fibrillation

Japan
Kumamoto University

Completed

Effects of Early Statin Treatment After Acute Myocardial Infarction (AMI) in Japanese Patients

Myocardial Infarction

Japan
Biosensors Europe SA
Biosensors Japan Co. Ltd.

Unknown

Leaders Free Japan

Coronary Disease

Japan
Boehringer Ingelheim

Completed

Treatment Pattern of Oral Anticoagulants (OAC) in Japan

Atrial Fibrillation

Japan
Nagoya University

Unknown

Investigation of Genetic Risk of Atrial Fibrillation

Atrial Fibrillation

Japan
OCEAN-SHD Study Group

Recruiting

Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation Trial

Aortic Stenosis | Aspirin | TAVI(Transcatheter Aortic Valve Implantation) | DAPT(Dual Antiplatelet Therapy) | SAPT(Single Antiplatelet Therapy)

Japan
Pfizer

Completed

Safety and Effectiveness of Apixaban in Very Elderly Patients With Non-valvular Atrial Fibrillation (NVAF) Compared to Warfarin Using Administrative Claims Data

Non-valvular Atrial Fibrillation

Japan
Osaka University
Cuorips Inc.

Recruiting

Clinical Trial of Human (Allogeneic) iPS Cell-derived Cardiomyocytes Sheet for Ischemic Cardiomyopathy

Myocardial Ischemia

Japan
Yokohama City University Medical Center

Unknown

The Effects of Ezetimibe on Coronary Plaque Volume in Patients With Acute Coronary Syndrome

Coronary Artery Disease

Japan
Takeda

Completed

Candesartan Cilexetil / Hydrochlorothiazide Combination Tablets Special Drug Use Surveillance: Long-term Use (12 Months)

Hypertension

Japan
Takeda

Completed

Candesartan Cilexetil Special Drug Use Surveillance 「Challenge - Quality Control」

Hypertension

Japan
Yoshio Matsui

Unknown

Comparison of Effect of cARvedilol Compared To bISoprolol on cenTral Pulse Pressure in Hypertension (ARTIST) Study

Hypertension

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Trial to Determine the Safety, Pharmacokinetics, and Efficacy of OPC-108459 Administered as a Single Intravenous Dose to Patients With Paroxysmal or Persistent Atrial Fibrillation (AF)

Atrial Fibrillation

Japan
Japan Cardiovascular Research Foundation

Unknown

GENERAL;GENeral Practitioners and Embolism pRevention in NVAF Patients Treated With RivAroxaban:reaL-life Evidence (GENeRAL)

Atrial Fibrillation

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Clinical Pharmacological Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)

Cardiac Edema

Japan
Juntendo University
Kumamoto University; Tokyo University; Kyoto University; Tohoku University; Yamaguchi...

Completed

Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy With Pitavastatin in Coronary Artery Disease (REAL-CAD)

Coronary Artery Disease

Japan
Kyoto Prefectural University of Medicine

Unknown

Anti-Restenosis After AMI by Erythropoietin

Acute Myocardial Infarction

Japan
National Cerebral and Cardiovascular Center

Recruiting

Japanese Lead Extraction Registry (J-LEX)

Arrhythmia, Cardiac

Japan
Biotronik Japan, Inc.

Completed

Safety and Efficacy Study of IPG Patient With Home Monitoring

Bradyarrhythmia

Japan
Japan Cardiovascular Research Foundation

Unknown

Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease Study (AFIRE)

Atrial Fibrillation

Japan
National Cerebral and Cardiovascular Center

Recruiting

Japanese Catheter Ablation Registry (J-AB)

Cardiac Arrhythmias | Catheter Ablation

Japan
Kumamoto University
Japan Heart Foundation

Completed

Pilot Study of Edaravone to Treat Acute Myocardial Infarction

Myocardial Infarction | Reperfusion Injury

Japan
Boehringer Ingelheim

Withdrawn

Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice

Hypertension

Japan
Jichi Medical University

Completed

A Study to Define the Distribution of Type of Hypertension in Asia by Blood Pressure Monitoring at Home (Asia BP@Home) (Asia BP@Home)

Hypertension

Japan
Novartis

Completed

SPP100 Dose Finding Study in Japan

Hypertension

Japan
Jichi Medical University

Completed

The Japan-Combined Treatment With Olmesartan and a Calcium Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study (J-CORE)

Hypertension

Japan
National Cerebral and Cardiovascular Center

Unknown

Atheroma Progression and Vulnerability Under Continuous Glucose Monitoring (OPTIMAL)

Coronary Atherosclerosis

Japan
Associations for Establishment of Evidence in Interventions

Completed

Nobori Dual Antiplatelet Therapy as Appropriate Duration

Coronary Artery Disease

Japan
Translational Research Center for Medical Innovation...
Wakayama Medical University

Completed

OPtical Frequency Domain Imaging Versus INtravascular Ultrasound in Percutaneous Coronary InterventiON - OPINION Imaging

Coronary Artery Disease

Japan
Ono Pharmaceutical Co. Ltd

Completed

Pilot Study of ONO-1101 in Patients Scheduled for Multi-slice CT

Coronary Artery Disease

Japan
Teva takeda

Active, not recruiting

A Study of Azilsartan in Children From 6 to Less Than 16 Years Old With High Blood Pressure

Hypertension

Japan
Boehringer Ingelheim

Completed

To Evaluate Real-world Safety, Effectiveness and Appropriate Use of Micatrio® Combination Tablets Treatment in Patients With Hypertension

Hypertension

Japan
Associations for Establishment of Evidence in Interventions

Unknown

Japan Unprotected Left Main Coronary Artery Disease Percutaneous Coronary Intervention (PCI) Strategy On New Generation Stents (J-LESSON)

Coronary Artery Disease

Japan
Translational Research Center for Medical Innovation...
Wakayama Medical University

Completed

OPtical Frequency Domain Imaging vs. INtravascular Ultrasound in Percutaneous Coronary InterventiON (OPINION)

Coronary Artery Disease

Japan
Kobe University

Recruiting

To Evaluate the Efficacy of Alirocumab for Neoatherosclerosis by Using OCT, in Comparison With Standard Statin Therapy (POLARIS)

Coronary Artery Disease Progression

Japan
Alcon Research

Completed

Alcon® Ex-PRESS® Glaucoma Filtration Device in Japanese Patients

Glaucoma

Japan
Sapporo Medical University
Merck Sharp & Dohme LLC

Completed

Is Glucagon-like Peptide-1 Insufficiency a Residual Risk in Coronary Artery Disease?

Coronary Artery Disease

Japan
Kumamoto University

Completed

CYP2C19 Gene Alteration and Thienopyridine Resistance in Percutaneous Coronary Intervention Study (CALDERA-PCI)

Stable Angina

Japan
Daiichi Sankyo Co., Ltd.

Completed

Study of CS-3150 in Patients With Severe Hypertension

Severe Hypertension

Japan
Daiichi Sankyo Co., Ltd.

Completed

Study of CS-3150 Compared to Olmesartan in Patients With Essential Hypertension

Essential Hypertension

Japan
Novartis

Completed

Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)

Hypertension

Japan
Novartis

Completed

A Study of VAH631 in Patients With Essential Hypertension (Factorial Study)

Hypertension

Japan
Tokyo University

Completed

Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine (ONEAST)

Essential Hypertension

Japan
Yokohama City University Medical Center
Teikyo University

Completed

Assessment of Distal Protection Device in Patients at High Risk for Distal Embolism in Acute Coronary Syndrome (ACS) (VAMPIRE3)

Coronary Artery Disease

Japan

3

Subscribe